RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles

Cancer Biology and Therapy

Volumn 8, Issue 7, 2009, Pages 594-598

  Luo, Guopei ^a   Jin, Chen ^a,b   Long, Jiang ^a   Fu, Deliang ^a   Yang, Feng ^a   Xu, Jin ^a   Yu, Xianjun ^a   Chen, Wei ^a   Ni, Quanxing ^a  

^a FUDAN UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Gene carriers; Methyl CpG binding domain protein 1; Nanoparticle; Poloxamer; Poly(d,l lactic co glycolic acid) (PLGA); RNA interference (RNAi)

Indexed keywords

GREEN FLUORESCENT PROTEIN; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; NANOPARTICLE; PLASMID DNA; POLOXAMER; POLYGLACTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MBD1 PROTEIN, HUMAN; NANOMATERIAL; POLYGLYCOLIC ACID; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CELL GROWTH; CYTOTOXICITY; DNA METHYLATION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NANOENCAPSULATION; PANCREAS CANCER; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; NANOSTRUCTURES; PANCREATIC NEOPLASMS; POLOXAMER; POLYGLYCOLIC ACID; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 66149145455     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.7.7790     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-130
2. Li XJ, Zheng Y, Shen YZ, Xiang YM, Han A. Study on Epidemiologic Status and Trend of Pancreatic Cancer in Shanghai. J Surg Concepts Pract 2002; 7:342-345
3. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21. (Pubitemid 34049633)
4. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60:1835-1839 (Pubitemid 30207640)
5. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-2054 (Pubitemid 37448928)
6. Di Y, Long J, Fu DL, Yu XJ, Jin C, Ni QX, et al. The elevation of methyl-CpG binding domain protein 1 in pancreatic carcinoma and its significance. J Surg Concepts Pract 2006; 11:35-38
7. Yu XJ, Long J, Fu DL, Zhang QH, Ni QX. Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray. Hepatobiliary Pancreat Dis Int 2003; 2:467-470 (Pubitemid 37069624)
8. Liu C, Chen Y, Yu X, Jin C, Xu J, Long J. Proteomic analysis of differential proteins in pancreatic carcinomas: effects of MBD1 knock-down by stable RNA interference. BMC Cancer 2008; 8:online.
9. Ryther RC, Flynt AS, Phillips JA, Patton JG. siRNA therapeutics: big potential from small RNAs. Gene Ther 2005; 12:5-11. (Pubitemid 40090039)
10. Ohada H, Heya T, Ogawa Y, Shimamoto T. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. J Pharmacol Exp Ther 1988; 244:744-750 (Pubitemid 18076624)
11. Csaba N, Caamaño P, Sánchez A, Domínguez F, Alonso MJ. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules 2005; 6:271-278 (Pubitemid 40277024)
12. Csaba N, Sánchez A, Alonso MJ. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. J Control Release 2006; 113:164-172 (Pubitemid 43928142)
13. Petersen H, Kunath K, Martin AL, Stolnik S, Roberts CJ, Davies MC, et al. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 2002; 3:926-936
14. Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 2002; 1:299-305.
15. Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod Pathol 2008; 21:238-244
16. Fujita N, Shimotake N, Ohki I, Chiba T, Saya H, Shirakawa M, et al. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol 2000; 20:5107-5118 (Pubitemid 30431564)
17. Jørgensen HF, Ben-Porath I, Bird AP. Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol Cell Biol 2004; 24:3387-3395 (Pubitemid 38452081)
18. Sarraf SA, Stancheva I. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 2004; 15:595-605. (Pubitemid 39141786)
19. Watanabe S, Ichimura T, Fujita N, Tsuruzoe S, Ohki I, Shirakawa M, et al. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci USA 2003; 100:12859-12864 (Pubitemid 37339990)
20. Lopez-Serra L, Ballestar E, Fraga MF, Alaminos M, Setien F, Esteller M. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res 2006; 66:8342-8346 (Pubitemid 44449141)
21. Anderson WF. Human gene therapy. Nature 1998; 392:25-30. (Pubitemid 28215190)
22. Langer R. Drug delivery. Drugs on target. Science 2001; 293:58-59
23. Lemieux P, Guérin N, Paradis G, Proulx R, Chistyakova L, Kabanov A, et al. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 2000; 7:986-991 (Pubitemid 30386664)
24. Park TG, Cohen S, Langer R. Controlled protein release from polyethyleneimine-coated poly(L-lactic acid)/pluronic blend matrices. Pharm Res 1992; 9:37-39